Top Companies
Form Screener
Cluster Buys
Sectors
FAQ
Feedback
Blog
Pricing
Login/Signup
Ambrx Biopharma Inc. (AMAM)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Billed Annually
SAVE 20%/mo!
Billed Monthly
Director
$50/mo
* Billed monthly
All Insider Trades
Monthly Newsletter
Unlimited Company Graphs
Download Data
Sector Insights
Custom Watchlists
Notifications
Real Time Emails
Direct Access to Team
Feature Requests
C-Suite
$75/mo
* Billed monthly
All Insider Trades
Monthly Newsletter
Unlimited Company Graphs
Download Data
Sector Insights
Custom Watchlists
Notifications
Real Time Emails
Direct Access to Team
Feature Requests
Checkout
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
15 Sep 2023
Cormorant Asset Management, LP
10% Owner
Ambrx Biopharma Inc.
(AMAM)
69,465,820
+3%
2,152,738
$9.12
$19,625,600.00
BUY
18 Apr 2023
Cormorant Asset Management, LP
10% Owner
Ambrx Biopharma Inc.
(AMAM)
67,313,090
+8%
5,215,189
$11.30
$58,950,692.00
BUY
13 Apr 2023
Cormorant Asset Management, LP
10% Owner
Ambrx Biopharma Inc.
(AMAM)
62,097,896
+4%
2,597,896
$9.75
$25,319,290.00
BUY
14 Mar 2023
Cormorant Asset Management, LP
10% Owner
Ambrx Biopharma Inc.
(AMAM)
53,500,000
+1%
1,000,000
$10.21
$10,211,400.00
Home